Delek US (NYSE: DK) EVP gets 9,842-share stock award

Rhea-AI Filing Summary

Spiegel Reuven reported acquisition or exercise transactions in this Form 4 filing.

Delek US Holdings EVP, Special Projects Reuven Spiegel received a grant of 9,842 shares of common stock as a time-vesting restricted stock unit award that vests over three years. After this compensation-related grant, his direct holdings increased to 58,372 common shares.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Spiegel Reuven

Role EVP, Special Projects

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	9,842	$0.00	--

Holdings After Transaction: Common Stock — 58,372 shares (Direct)

Footnotes (1)

1. [object Object]

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Spiegel Reuven

(Last) (First) (Middle)

310 SEVEN SPRINGS WAY

SUITE 500

(Street)

BRENTWOOD TN 37027

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Delek US Holdings, Inc. [ DK ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, Special Projects

3. Date of Earliest Transaction (Month/Day/Year)
03/10/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/10/2026		A(1)		9,842	A	$0	58,372	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents a grant of time-vesting restricted stock units that vest over three years.

Remarks:

	/s/ Misty Lavender, Attorney in Fact	03/11/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Delek US (DK) executive Reuven Spiegel report in this Form 4?

Reuven Spiegel reported receiving 9,842 shares of Delek US common stock as a time-vesting restricted stock unit grant. The award vests over three years and reflects equity-based compensation rather than an open-market stock purchase or sale.

How many Delek US (DK) shares does Reuven Spiegel hold after this grant?

After the restricted stock unit grant, Reuven Spiegel directly holds 58,372 shares of Delek US common stock. This total includes the newly awarded 9,842 shares, which are subject to three-year time-based vesting conditions as described in the filing footnote.

Was the Delek US (DK) Form 4 transaction a stock purchase or sale?

The Form 4 transaction was not a market purchase or sale. It reflects a grant of 9,842 time-vesting restricted stock units awarded as compensation, with no price paid per share and vesting scheduled over a three-year period.

What are the terms of the restricted stock units granted at Delek US (DK)?

The reported restricted stock units represent a grant of 9,842 shares of common stock that vest over three years. The award is time-vesting, meaning Spiegel must satisfy service-based conditions across the vesting period for the shares to fully vest.

Does this Delek US (DK) Form 4 indicate any derivative securities activity?

No derivative securities activity is reported in this Form 4. The filing only shows a non-derivative transaction: a grant of 9,842 time-vesting restricted stock units tied to Delek US common stock, increasing Spiegel’s direct share holdings to 58,372.